Hussam I Kutbi1, Ahmed K Kammoun2, Dalia Farag El-Telbany3. 1. Department of Pharmacy Practice, Faculty of Pharmacy, King Abdulaziz University, Jeddah, 21589, Saudi Arabia. 2. Department of Pharmaceutical Chemistry, Faculty of Pharmacy, King Abdulaziz University, Jeddah, 21589, Saudi Arabia. 3. Department of Pharmaceutics, Faculty of Pharmacy, Modern University for Technology and Information (MTI), Cairo, 11571, Egypt.
Abstract
PURPOSE: This study aimed to explain the influence of zein nanosphere (ZN NS) formulation on the pharmacotherapeutic profile of PTS in MCF7 cells. METHODS: Liquid-liquid phase separation was used to formulate PTS-ZN NSs. The formulations developed were evaluated for particle-size analysis, encapsulation efficiency, and in vitro diffusion. Also, assays of cytotoxicity, uptake, cell-cycle progression, annexin V, apoptotic gene mRNA expression and biochemical assays were carried out. RESULTS: The PTS-ZN NS formulation selected showed 104.5±6.2 nm, 33.4±1.8 mV, 95.1%±3.6%, and 89.1%±2.65% average particle size, zeta-potential, encapsulation efficiency and in vitro diffusion, respectively. With MCF7 cells, IC50 was reduced approximately 15-fold, with increased cellular uptake, accumulation in the G2/M phase, increased percentage of cells in the pre-G1 phase, amelioration of early and late apoptosis, raised mRNA expression of CASP3 and CASP7, lower expression of cyclin-CDK1, and enhanced oxidant potential through decreased glutathione reductase (GR) activity, and enhanced reactive oxygen-species generation and lipid-peroxidation products. CONCLUSION: PTS-ZN NSs indicated enhanced antiproliferative, proapoptotic, and oxidant potential toward MCF7 cells compared to free PTS. Ameliorated results of nanosized carriers, cellular uptake, and sustained diffusion may contribute to these outcomes.
PURPOSE: This study aimed to explain the influence of zein nanosphere (ZN NS) formulation on the pharmacotherapeutic profile of PTS in MCF7 cells. METHODS: Liquid-liquid phase separation was used to formulate PTS-ZN NSs. The formulations developed were evaluated for particle-size analysis, encapsulation efficiency, and in vitro diffusion. Also, assays of cytotoxicity, uptake, cell-cycle progression, annexin V, apoptotic gene mRNA expression and biochemical assays were carried out. RESULTS: The PTS-ZN NS formulation selected showed 104.5±6.2 nm, 33.4±1.8 mV, 95.1%±3.6%, and 89.1%±2.65% average particle size, zeta-potential, encapsulation efficiency and in vitro diffusion, respectively. With MCF7 cells, IC50 was reduced approximately 15-fold, with increased cellular uptake, accumulation in the G2/M phase, increased percentage of cells in the pre-G1 phase, amelioration of early and late apoptosis, raised mRNA expression of CASP3 and CASP7, lower expression of cyclin-CDK1, and enhanced oxidant potential through decreased glutathione reductase (GR) activity, and enhanced reactive oxygen-species generation and lipid-peroxidation products. CONCLUSION: PTS-ZN NSs indicated enhanced antiproliferative, proapoptotic, and oxidant potential toward MCF7 cells compared to free PTS. Ameliorated results of nanosized carriers, cellular uptake, and sustained diffusion may contribute to these outcomes.
Authors: Mardi M Algandaby; Majid M Al-Sawahli; Osama A A Ahmed; Usama A Fahmy; Hossam M Abdallah; Masao Hattori; Osama M Ashour; Ashraf B Abdel-Naim Journal: J Biomed Nanotechnol Date: 2016-09 Impact factor: 4.099
Authors: Valeria De Matteis; Loris Rizzello; Chiara Ingrosso; Eva Liatsi-Douvitsa; Maria Luisa De Giorgi; Giovanni De Matteis; Rosaria Rinaldi Journal: Nanomaterials (Basel) Date: 2019-10-30 Impact factor: 5.076
Authors: Ahmed K Kammoun; Maha A Hegazy; Alaa Khedr; Zuhier Ahmed Awan; Maan T Khayat; Majid Mohammad Al-Sawahli Journal: Pharmaceuticals (Basel) Date: 2022-07-24
Authors: Maan T Khayat; Mohamed A Zarka; Dalia Farag A El-Telbany; Ali M El-Halawany; Hussam Ibrahim Kutbi; Walid F Elkhatib; Ayman M Noreddin; Ahdab N Khayyat; Rania Farag A El-Telbany; Sherif F Hammad; Ashraf B Abdel-Naim; Ebtesam M Alolayan; Majid Mohammad Al-Sawahli Journal: Sci Rep Date: 2022-09-08 Impact factor: 4.996